The mission of the Tufts
Health Care Institute Program on Opioid Risk Management is to address challenges
in the development and utilization of opioid analgesics, by engaging a multidisciplinary
group of stakeholders focused on optimizing the benefits of opioid for pain management,
and minimizing their risks, including abuse and diversion.
July 23 & 24, 2009
Risk Evaluation and Mitigation Strategy for Prescription
Opioids: An In-Depth Review of Fundamental Issues
Nathaniel Katz, MD, MS Presentation
Michael Klein, Ph.D. Presentation
How Industry Uses Root Causes Analysis to Manage
Risk and Linkage to REMS Intervention
John Carroll, PhD Presentation >>
What is the Public Health Rationale for Prescription Opioid
REMS to Addressing Public Health Concerns
John Brownstein, PhD Presentation
The REMS Experience: Update and Review
Edgar Adams, ScD Executive Director, Epidemiology Presentation >>
Practitioner Education: What are the Core Elements of
Safe Opioid Prescribing?
Lynn Webster, MD Presentation
Practitioner Education: What Forms of Training and Feedback
will Change Practitioner Behavior?
Thomas Kosten, MD Presentation
Patient Education: What Do We Want Patients Do with their
Seddon Savage, MS, MD Presentation >>
Patient Education: What Methods do Practitioners Use to
Train Patients to Respect Opioids?
Will Rowe Presentation >>
Unintended Consequences: Potential Patient Barriers to
Accessing Prescription Opioids Because of REMS
Richard Payne, MD, PhD Presentation >>
Retail Pharmacy REMS for Opioids; Challenges and Solutions
Roger Pinsonneault, RPh Presentation >>
Distribution of Controlled Substances in the US: A Primer
Anita Ducca, MS Presentation >>
How Do We Evaluate the Effectiveness of REMS: Core Requirements
Nabarun Dasgupta, MPH Presentation >>
Concurrent Workgroup Breakouts
Breakout Group 1: Practitioners
• What desired practitioner behaviors do we want?
• What is safe-opioid prescribing behavior?
• What are the key elements of safe practice?
• Develop a checklist that physicians can use
on a systematic basis with patients.
Breakout Group 2: Patients:
• What are the patient behaviors that we want to decrease abuse?
• What do we want patients to do?
• How do we know if they are following suggestions?
• Develop a checklist that patients can receive and implement to reduce abuse, accidental
ingestion, or access.
Breakout Group 3: Pharmacists' Behavior:
Breakout Group 3: Standards for Evaluation of REMS Programs: